Greater Cannabis Company, Inc. Cash and Equivalents

Quick Answer

Greater Cannabis Company, Inc. reported Cash and Equivalents of $166.9 thousand for fiscal year 2023.

Greater Cannabis Company, Inc. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2023 $166.9K -38.2%
2022 $270.0K -28.5%
2021 $377.5K +234.2%
2020 $113.0K +358.0%
2019 $24.7K -58.8%
2018 $59.9K +5931.3%
2017 $993.00

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2024 $62.3K -68.8% -22.5%
June 30, 2024 $80.3K -66.6% -37.9%
March 31, 2024 $129.3K -48.6% -22.5%
December 31, 2023 $166.9K -38.2% -16.4%
September 30, 2023 $199.5K -31.0% -17.1%
June 30, 2023 $240.7K -22.6% -4.3%
March 31, 2023 $251.6K -31.6% -6.8%
December 31, 2022 $270.0K -28.5% -6.6%
  • Greater Cannabis Company, Inc. showed a decrease of -38.2% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2017–2023 period, Greater Cannabis Company, Inc.’s cash and equivalents has grown by 16703.5% (from $993.00 to $166.9 thousand).
  • The most recent figure is from Greater Cannabis Company, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 1, 2024.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment